This postulate is inconsistent with studies that found sulforaphane upregulated Nrf2 target genes in type 2 diabetics [88] and obese patients [87], who also have high levels of oxidative stress and low grade inflammation. Here, NFE2L2 is linked to type 2 diabetes mellitus.